Abstract CT132: Orelabrutinib, a potent and selective Bruton's tyrosine kinase inhibitor with superior safety profile and excellent PK/PD properties
暂无分享,去创建一个
S. Shakib | Renbin Zhao | Bin Zhang | R. Liang | Yingxiang Gao | Zhengguang Lu | Richard Liu | Chen Xiangyang | Wang Zuo-peng | Yu Li-Qin | J. Cui | Xiangyang Chen | Zuo-Peng Wang | Li-Qin Yu